![]() Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. (Pharm), PharmD, ACPR, St Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada ģ Lower Mainland Pharmacy Services, 2733 Heather Street, Vancouver, BC, Canada Ĥ Royal Columbian Hospital, 330 E Columbia Street, New Westminster, BC, Canada ĥ Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC, Canada Ħ St Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada.Ĭonflict-of-interest statement: The author(s) declare(s) that there is no conflict of interest regarding the publication of this paper. (Pharm), PharmD, FCSHP, BCPS(AQ), BCCPġ Surrey Memorial Hospital, 13750 96 Ave, Surrey, BC, Canada Ģ Cindy San, B.Sc. (Pharm), PharmD, ACPR Katherin Badke5, B.Sc. ![]() Clinical Effectiveness of Idarucizumab in Dabigatran Reversal
0 Comments
Leave a Reply. |